CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,266,331 | +234.1% | 108,326 | +8.1% | 0.03% | -18.9% |
| Q3 2018 | $379,000 | +44.1% | 100,181 | +19.0% | 0.04% | +60.9% |
| Q2 2018 | $263,000 | -10.5% | 84,181 | -31.6% | 0.02% | -34.3% |
| Q1 2018 | $294,000 | +54.7% | 123,000 | +78.3% | 0.04% | -12.5% |
| Q2 2017 | $190,000 | -28.3% | 68,970 | -49.2% | 0.04% | -18.4% |
| Q1 2017 | $265,000 | +173.2% | 135,872 | +242.3% | 0.05% | +14.0% |
| Q4 2015 | $97,000 | -49.2% | 39,695 | -37.7% | 0.04% | -52.7% |
| Q3 2015 | $191,000 | – | 63,667 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |